Interferon alfa-2a.
Copyright policy )Interferon alfa-2a.
Interferon alfa-2a shows both antiviral and antitumoral activity, but its role in the treatment of many conditions remains controversial. It is, however, the treatment of choice for chronic, active hepatitis B, chronic hepatitis C and AIDS-related Kaposi's sarcoma, and is also effective in metastatic renal carcinoma and chronic myelogenous leukaemia. Optimal dose regimens are unclear, and further randomized trials are needed.
- University College London United Kingdom
Leukemia, Hairy Cell, Cost-Benefit Analysis, Lymphoma, Non-Hodgkin, Interferon-alpha, Antineoplastic Agents, Interferon alpha-2, Hepatitis B, Antiviral Agents, Hepatitis C, Kidney Neoplasms, Recombinant Proteins, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Humans, Multiple Myeloma, Sarcoma, Kaposi
Leukemia, Hairy Cell, Cost-Benefit Analysis, Lymphoma, Non-Hodgkin, Interferon-alpha, Antineoplastic Agents, Interferon alpha-2, Hepatitis B, Antiviral Agents, Hepatitis C, Kidney Neoplasms, Recombinant Proteins, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Humans, Multiple Myeloma, Sarcoma, Kaposi
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).12 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!